TP53 and neoplasm: But the promoter methylation levels of UBE2C gene was lower in TP53 mutant tumor samples, indicating that the promoter methylation level of UBE2C gene could be applied to distinguish TP53 mutant and non-mutant samples as a diagnostic biomarker.